Form 8-K - Current report:
SEC Accession No. 0000819050-20-000018
Filing Date
2020-02-10
Accepted
2020-02-10 16:58:52
Documents
2
Period of Report
2020-02-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a2020028k.htm 8-K 27085
2 EXHIBIT 99.1 a2020028kexhibit991.htm EX-99.1 209022
  Complete submission text file 0000819050-20-000018.txt   237477
Mailing Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301
Business Address 5777 CENTRAL AVENUE SUITE 102 BOULDER CO 80301 (720) 505-4755
Brickell Biotech, Inc. (Filer) CIK: 0000819050 (see all company filings)

EIN.: 930948554 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21088 | Film No.: 20592747
SIC: 2836 Biological Products, (No Diagnostic Substances)